Clinical trial
To Investigate Effects GSK561679 on Part of the Body's System That Controls the…
NCT00426608 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00426608 |
|---|---|
| Title | To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones. |
| Official title | Placebo-Controlled, Randomized, Blinded, Double-Dummy, Crossover Study to Investigate the Attenuation of ACTH Activation Induced by Metyrapone With a Single Dose of GSK561679 or Alprazolam in Healthy Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depressive Disorder and Anxiety Disorders |
| Intervention type | Drug |
| Interventions | metyrapone, alprazolam, placebo, GSK561679 |
| Enrollment | 20 |
| Start date | Oct 6, 2006 |
| Primary completion | Jan 8, 2007 |
| Completion | Jan 8, 2007 |
| First posted | Jan 25, 2007 |
| Last update posted | Sep 11, 2017 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: